AI-Assistance Body Composition CT at T12 and T4 in Lung Cancer: Diagnosing Sarcopenia, and Its Correlation with Morphofunctional Assessment Techniques
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index; none of the 57 sources its claims cite is checked for support yet.
Abstract
Background: Sarcopenia and low muscle mass are prevalent and prognostically relevant in patients with lung cancer, yet their diagnosis remains challenging in routine clinical practice. Opportunistic assessment using computed tomography (CT) has emerged as a valuable tool for body composition evaluation. We aimed to assess the utility of thoracic CT at T12 and T4 levels in identifying sarcopenia and low muscle mass and explore their correlation with morphofunctional tools such as bioelectrical impedance vector analysis (BIVA), nutritional ultrasound (NU), and functional performance tests. Methods: In this prospective observational study, 80 patients with lung cancer were evaluated at diagnosis. Body composition was assessed using BIVA-, NU-, and CT-derived parameters at T12 and T4 levels. Functional status was measured using the Timed Up and Go (TUG) and 30-Second Chair Stand Test. Sarcopenia was defined according to EWGSOP2 criteria. Results: Sarcopenia was identified in 20% of patients. CT-derived indices at T12CT demonstrated better diagnostic performance than T4CT. For detecting low muscle mass, the optimal SMI cut-off values were SMI_T12CT < 31.98 cm2/m2 and SMI_T4CT < 59.05 cm2/m2 in men and SMI_T12CT < 28.23 cm2/m2 and SMI_T4CT < 41.69 cm2/m2 in women. For sarcopenia diagnosis, the values were SMI_T12CT < 24.78 cm2/m2 and SMI_T4CT < 57.23 cm2/m2 in men and SMI_T12CT < 21.24 cm2/m2 and SMI_T4CT < 49.35 cm2/m2 in women. A combined model including SMI_T12CT, RF_CSA, and the 30 s squat test showed high diagnostic accuracy (AUC = 0.826). In multivariable analysis, lower SMA_T12CT was independently associated with risk of sarcopenia (OR = 0.96, 95% CI: 0.92–0.99, p = 0.022), as were older age (OR = 1.23, 95% CI: 1.07–1.47, p = 0.010) and fewer repetitions in the 30 s squat test (OR = 0.78, 95% CI: 0.63–0.91, p = 0.007). Conclusions: CT-derived body composition assessment, particularly at the T12 level, shows good correlation with morphofunctional tools and may offer a reliable and timely alternative for identifying sarcopenia and low muscle mass in patients with lung cancer.
Overview
CoChat Summary
TL;DR
In 80 patients with lung cancer, CT-derived body composition at T12 performed better than T4 for identifying low muscle mass and sarcopenia, with sarcopenia found in 20% by EWGSOP2 criteria. A combined model using SMI_T12CT, rectus femoris cross-sectional area, and the 30 s squat test achieved good diagnostic accuracy (AUC = 0.826).
Key findings
- Sarcopenia was identified in 20% of patients; 53.8% had low muscle mass when combining low ASMM and/or low ASMI.
- T12CT showed better diagnostic performance than T4CT: for low muscle mass, optimal SMI cut-offs were SMI_T12CT < 31.98 cm²/m² and SMI_T4CT < 59.05 cm²/m² in men, and SMI_T12CT < 28.23 cm²/m² and SMI_T4CT < 41.69 cm²/m² in women.
- For sarcopenia diagnosis, cut-offs were SMI_T12CT < 24.78 cm²/m² and SMI_T4CT < 57.23 cm²/m² in men, and SMI_T12CT < 21.24 cm²/m² and SMI_T4CT < 49.35 cm²/m² in women.
- In multivariable analysis, lower SMA_T12CT (OR = 0.96, 95% CI: 0.92–0.99, p = 0.022), older age (OR = 1.23, 95% CI: 1.07–1.47, p = 0.010), and fewer 30 s squat repetitions (OR = 0.78, 95% CI: 0.63–0.91, p = 0.007) were independently associated with sarcopenia.
Methods
- Prospective, observational, single-centre study of 80 patients with lung cancer evaluated at diagnosis at the Endocrinology and Nutrition Unit of Virgen de la Victoria University Hospital.
- Body composition was assessed using BIVA, nutritional ultrasound, and CT-derived parameters at T12 and T4 levels via FocusedON® software; functional status used handgrip strength, Timed Up and Go, and 30-Second Chair Stand Test; sarcopenia was defined by EWGSOP2 criteria.
- Analysis included ROC curves with Youden index for cut-offs, correlation analyses, and multivariable logistic regression for sarcopenia predictors.
Limitations
- The paper states small sample size and limited number of sarcopenic patients may reduce statistical power and generalizability; single-centre design may restrict external validity; cohort was predominantly male, limiting applicability to female populations.
- The paper also notes lack of standardized reference values for thoracic CT-defined sarcopenia, modest AUC values and variability in sensitivity/specificity, and that FocusedON® remains an emerging methodology requiring further validation; residual confounding is possible.
- Evident from the text: the study reports no external validation cohort and no longitudinal outcome data, so clinical utility for predicting outcomes is not established here.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
0 Valid · 0 Not valid · 20 Not checked · 121 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A lower proportion of sarcopenic individuals underwent surgery (5.0% vs. 27.5%), received radiotherapy (5.1% vs. 26.6%), chemotherapy (5.1% vs. 40.5%), or immunotherapy (3.8% vs. 22.8%).”
§ AI-Assistance Body Composition CT at T12 and T4 in Lung Cancer: Diagnosing Sarcopenia, and Its Correlation with Morphofunctional Assessment Techniques > 3. Results > 3.1. Demographic, Clinicopathological and Body Composition Characteristics Between Sarcopenic and Non-Sarcopenic According to EWGSOP2 Criteria
plainstates an associationn = 80- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For sarcopenia diagnosis, the values were SMI_T12CT < 24.78 cm2/m2 and SMI_T4CT < 57.23 cm2/m2 in men”
§ AI-Assistance Body Composition CT at T12 and T4 in Lung Cancer: Diagnosing Sarcopenia, and Its Correlation with Morphofunctional Assessment Techniques > Abstract
plainn = 80- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
None of the sources cited for this claim have been checked yet.
In the paper
“Sarcopenic patients were significantly older, had lower muscle mass and function, a lower BMI and a higher ECOG [9,27].”
§ AI-Assistance Body Composition CT at T12 and T4 in Lung Cancer: Diagnosing Sarcopenia, and Its Correlation with Morphofunctional Assessment Techniques > 4. Discussion
What the sources say
- Not checked yetcites [9] Kaltenhauser, S., Niessen, C., Zeman, F., Stroszczynski, C., Zorger, N., Grosse, J., Großer, C., Hofmann, H.S., and Robold, T. (2023). Diagnosis of sarcopenia on thoracic computed tomography and its association with postoperative survival after anatomic lung cancer resection. Sci. Rep., 13. source
- Not checked yetcites [27] Ying, L., Xu, L., Yang, J., and Zhang, Q. (2024). Prognostic significance of CT-determined sarcopenia in older patients with advanced squamous cell lung cancer treated with programmed death-1 inhibitors. Sci. Rep., 14. source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A combined model including SMI_T12CT, RF_CSA, and the 30 s squat test showed high diagnostic accuracy (AUC = 0.826).”
§ AI-Assistance Body Composition CT at T12 and T4 in Lung Cancer: Diagnosing Sarcopenia, and Its Correlation with Morphofunctional Assessment Techniques > Abstract
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and fewer repetitions in the 30 s squat test (OR = 0.78, 95% CI: 0.63–0.91, p = 0.007)”
§ AI-Assistance Body Composition CT at T12 and T4 in Lung Cancer: Diagnosing Sarcopenia, and Its Correlation with Morphofunctional Assessment Techniques > Abstract
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
89 more claims
Create a free account to see all 141 claims and to verify the 57 references still open.
- It may state two separate claims as one. 36
- The quote only partly states this claim. 1
- Probably not a substantial claim. 18
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ AI-Assistance Body Composition CT at T12 and T4 in Lung Cancer: Diagnosing Sarcopenia, and Its Correlation with Morphofunctional Assessment Techniques > 3. Results > 3.4. Integrated Diagnostic Models for Sarcopenia: Multimodal Performance and Independent Predictors
“The optimal cut-off points identified were 21.23 kg/m2 for SMI_T12CT”
§ AI-Assistance Body Composition CT at T12 and T4 in Lung Cancer: Diagnosing Sarcopenia, and Its Correlation with Morphofunctional Assessment Techniques > 2. Materials and Methods > 2.2. Anthropometric and Body Composition Assessments
“the skeletal muscle index (SMI, articulated in cm2/m2, adjusted for patient height)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ AI-Assistance Body Composition CT at T12 and T4 in Lung Cancer: Diagnosing Sarcopenia, and Its Correlation with Morphofunctional Assessment Techniques > 3. Results > 3.2. Correlation Between Morphofunctional Parameters (Muscle and Fat Tissue) and Sarcopenia Criteria
“SMI_T12CT (r = −53)”
§ AI-Assistance Body Composition CT at T12 and T4 in Lung Cancer: Diagnosing Sarcopenia, and Its Correlation with Morphofunctional Assessment Techniques > 3. Results > 3.2. Correlation Between Morphofunctional Parameters (Muscle and Fat Tissue) and Sarcopenia Criteria
“with the strongest being SMI (r = −0.68)”
Citations
Cites
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Sarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601
Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186
Definition and classification of cancer cachexia: an international consensus
Fearon, K., Strasser, F., Anker, S. D., Bosaeus, I., Bruera, E., Fainsinger, R. L., Jatoi, A., Loprinzi, C., MacDonald, N., Mantovani, G., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70218-7 · Cited by 5,767
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Prado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., & Baracos, V. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70153-0 · Cited by 3,238
Hand grip strength: Outcome predictor and marker of nutritional status
Norman, K., Stobäus, N., Gonzalez, M. C., Schulzke, J.-D., & Pirlich, M. (2011) · Clinical Nutrition · doi:10.1016/j.clnu.2010.09.010 · Cited by 1,060
Celis-Morales, C. A., Welsh, P., Lyall, D. M., Steell, L., Petermann, F., Anderson, J., Iliodromiti, S., Sillars, A., Graham, N., Mackay, D. F., et al. (2018) · BMJ · doi:10.1136/bmj.k1651 · Cited by 772
A new method for monitoring body fluid variation by bioimpedance analysis: The RXc graph
Piccoli, A., Rossi, B., Pillon, L., & Bucciante, G. (1994) · Kidney International · doi:10.1038/ki.1994.305 · Cited by 711
Derstine, B. A., Holcombe, S. A., Ross, B. E., Wang, N. C., Su, G. L., & Wang, S. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-29825-5 · Cited by 507 · cited 3×
“SMI cutoffs for males/females, respectively, were 28.7/20.6 (T12) and 44.6/34.0 (L3) [26,41].”
Influential
Cited by
Forné, Á. F., Fernández‐Jiménez, R., Toledo, M. D., Jiménez-Rodríguez, H., Muñoz-Lupiáñez, M., Ruiz-López, M. A., García‐Almeida, J. M., la Peña-Fernández, L. D., Queipo‐Ortuño, M. I., & Gómez‐Millán, J. (2025) · Nutrients · doi:10.3390/nu17203301 · Cited by 1
Self-citationHarmes, J. C., Holtkamp, M., Straus, J., Jošt, G., Forsting, M., Hosch, R., Nensa, F., Pietsch, H., Salhöfer, L., & Haubold, J. (2026) · Scientific Reports · doi:10.1038/s41598-026-55169-6
Romero‐Márquez, J. M., González‐Pacheco, M., Fernández‐Jiménez, R., Carmona‐Llanos, A., Zarco-Martín, M. T., Gómez, P. R. D. V., Mucarzel, F., García-Rey, S., Sanz-Sanz, A., Pérez, M. I. R., et al. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1876352
Self-citationYou, Z., Dai, W., Shen, H., Wei, X., Cheng, L., Liao, J. X., Cao, J., Li, M., Wang, J., Shao, M., et al. (2026) · Cancer Medicine · doi:10.1002/cam4.72230
Razat, L., Degano, B., & Betry, C. (2026) · Clinical Nutrition · doi:10.1016/j.clnu.2026.106792
Metadata
- Authors
- Montero-Benitez, M. Z., Carmona-Llanos, A., Fernández-Jiménez, R., Román-Jobacho, A., Gómez-Millán, J., Modamio-Molina, J., Cabrera-Cesar, E., Vegas-Aguilar, I., Amaya-Campos, M. D. M., Tinahones, F. J., Molina-Montes, E., Cayón-Blanco, M., & García-Almeida, J. M.
- Affiliations
- Departament of Endocrinology and Nutrition, Jerez Universitary Hospital, 11407 Jerez de la Frontera, Spain
- Departament of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, 29010 Málaga, Spain
- Department of Radiación Oncology, Virgen de la Victoria University Hospital, 29010 Málaga, Spain
- Instituto de Investigación Biomédica y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29590 Málaga, Spain
- Hospital Universitario del Sureste (ES)
- Department of Neumology, Virgen de la Victoria University Hospital, 29010 Málaga, Spain
- Andalusian Centre for Nanomedicine and Biotechnology (ES)
- Instituto de Salud Carlos III (ES)
- Departament of Nutrition and Food Sciencie, University of Granada, 18071 Granada, Spain
- Hospital Universitario de Jerez (ES)
- ORCID
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2025-10-08
- Volume
- 17
- Issue
- 19
- Pages
- 3255
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC12524087
- OpenAlex
- W4414930279
- Cited by
- 7
- References
- 44
- Citations by year
- 2026: 6 · 2025: 1
- FWCI
- 3.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
- Keywords
- sarcopenia, lung cancer, body composition, skeletal muscle index, bioelectrical impedance vector analysis, functional performance, Timed Up and Go test, 30-second chair stand test, EWGSOP2 criteria, sarcopenia risk factors, prognostic factors, low muscle mass
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-21, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-21 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: AI-Assistance Body Composition CT at T12 and T4 in Lung Cancer: Diagnosing Sarcopenia, and Its Correlation with Morphofunctional Assessment Techniques. https://app.cochat.ai/papers/10.3390/cancers17193255
- The paper
- Montero-Benitez, M. Z., Carmona-Llanos, A., Fernández-Jiménez, R., Román-Jobacho, A., Gómez-Millán, J., Modamio-Molina, J., Cabrera-Cesar, E., Vegas-Aguilar, I., Amaya-Campos, M. D. M., Tinahones, F. J., Molina-Montes, E., Cayón-Blanco, M., & García-Almeida, J. M. (2025). AI-Assistance Body Composition CT at T12 and T4 in Lung Cancer: Diagnosing Sarcopenia, and Its Correlation with Morphofunctional Assessment Techniques. Cancers. https://doi.org/10.3390/cancers17193255
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.